7Irfan M,Hussain SF,Mapara K,et al.Community acquired pneumonia:risk factors associated with mortality in a tertiary care hospitalized patients[J].J Pak Med Assoc,2009,59(7):448-452.
8File TM.The science of selecting antimicrobials for community-acquired pneumonia (CAP)[J].J Manag Care Pharm,2009,15(2 Suppl):S5-11.
9Falguera M,Trujilano J,Caro S,et al.A prediction rule for estimating the risk of bacteremia in patients with community-acquired pneumonia[J].Clin Infect Dis,2009,49(3):409-416.
10Farah R,Makhoul N.Levels of fibrinogen compared to crp in plasma as new marker in diagnosis of pulmonary edema of non septic origin[J].Harefuah,2006,145(12):870-874,943-944.
5Song SW,Yang HS,Lee S,et al.Earlier application of percutaneous cardiopulmonary support rescues patients from severe cardiopulmonary failure using the APACHE III scoring system[J].J Korean Med Sci,2009,24(6):1064-1070.
6Chang YT,Yang YH,Chiang BL.The significance of a rapid cold hemagglutination test for detecting Mycoplasma infections in children with asthma exacerbation[J].J Microbiol Immunol Infect,2006,39(1):28-32.
7Peiris JS,Yu WC,Leung CW,et al.Re-emergence of fatal human influenza a subtype H5N1disease[J].Lancet,2004,363(9409):617-619.
8Lee SC,Hua CC,Yu TJ,et al.Risk factors of mortality for nosocomial pneumonia:importance of initial anti-microbialtherapy[J].Int J Clin Pract,2005,59(1):39-45.
